Cargando…
Dual antivascular function of human fibulin‐3 variant, a potential new drug discovery strategy for glioblastoma
The ECM protein EFEMP1 (fibulin‐3) is associated with all types of solid tumor through its cell context‐dependent dual function. A variant of fibulin‐3 was engineered by truncation and mutation to alleviate its oncogenic function, specifically the proinvasive role in glioblastoma multiforme (GBM) ce...
Autores principales: | Ke, Chao, Luo, Jun‐ran, Cen, Zi‐wen, Li, Yanyan, Cai, Hai‐ping, Wang, Jing, Chen, Fu‐rong, Siegel, Eric R., Le, Kody N., Winokan, Jesica R., Gibson, Grace J., McSwain, Asia E., Afrasiabi, Kambiz, Linskey, Mark E., Zhou, You‐Xin, Chen, Zhong‐ping, Zhou, Yi‐Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060460/ https://www.ncbi.nlm.nih.gov/pubmed/31922633 http://dx.doi.org/10.1111/cas.14300 |
Ejemplares similares
-
Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models
por: Li, Yanyan, et al.
Publicado: (2017) -
Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease
por: Afrasiabi, Kambiz, et al.
Publicado: (2020) -
Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21(st) century cancer therapeutics
por: Zhou, Yi-Hong, et al.
Publicado: (2016) -
Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010) -
Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer
por: Ma, Xiaocong, et al.
Publicado: (2023)